Tuesday, September 1, 2020

Akums Drugs & Pharmaceuticals Ltd Hiring EXECUTIVE- PHARMACOVIGILANCE B.Pharm / M.Pharm Apply Now

Akums Drugs & Pharmaceuticals Ltd Hiring EXECUTIVE- PHARMACOVIGILANCE B.Pharm / M.Pharm Apply Now


Job Location:- Haridwar (Uttrakhand)


Responsible for PSUR (Periodic Safety Update Report) development and submission to applicable regulatory authority.


To assist in pharmacovigilance training to team members and other departments related to PV procedures and regulatory obligations.


To assist head of the department in preparation /revision of Standard Operating Procedures/Work Instructions.


Responsible for conducting overall Pharmacovigilance activities and maintenance of Pharmacovigilance (PV) safety database.


Responsible for preparation and maintenance of Pharmacovigilance System Master File (PSMF).


Responsible for global and local literature surveillance.


Responsible for ICSR management and submission to applicable regulatory authority.


Responsible for development and maintenance of PV Safety Data Exchange Agreement (SDEA) of different clients.


To review and approve final ADR/AE assessment report and related activities.


Responsible for handling and reporting of all SAEs to DCGI and other applicable regulatory authority.


Responsible for RMP (Risk Management Plan) development and submission to applicable regulatory authority.


Responsible for Signal detection and continuous monitoring of safety profile of all medical products.


Responsible for coordinating with different Marketing Authorization Holders (MAHs)/ clients/ Regulatory Authorities on a 24 hour basis related to Pharmacovigilance activities & queries.


Responsible for PMS (Post Marketing Surveillance) studies/ non interventional observational cohort studies etc.


Will be involved in audit/inspection plans and Corrective Actions Preventative Actions (CAPAs).


To evaluate potential medically relevant pharmaceutical product complaints.


TO APPLY CLICK HERE

FOR MORE JOB UPDATES



JOIN IN GROUP FOR DAILY UPDATES


No comments:

Post a Comment